About 15 million doses of Johnson & Johnson’s covid-19 vaccine were mistakenly wasted at a plant in Baltimore.
According to the New York Times, quoted by the agency France-Presse, a few weeks ago employees of a factory in Baltimore, managed by Emergent BioSolutions, a partner of Johnson & Johnson, confused the ingredients necessary for the manufacture of the vaccine.
Contacted by AFP, Johnson & Johnson did not confirm the figure of 15 million, but stated that quality checks carried out in place “identified a batch of drug substance that did not meet the quality standards of Emergent BioSolutions, a unit that is not yet authorized to manufacture the drug substance for our vaccine against covid-19 “.
“This batch did not go through the filling and finishing stages of our manufacturing process,” added the pharmaceutical company in a statement.
The American drug agency (FDA) was notified of the situation and “supplementary specialists” were moved to the site to oversee operations, according to the company.
“In coordination with the US Department of Health, these measures will allow us to safely deliver 24 million doses of the vaccine during the month of April,” said Johnson & Johnson.
The “New York Time” s needs that the doses of the vaccine currently delivered in the United States are not affected, because they are manufactured in the Netherlands.
However, future deliveries are expected to originate at the Baltimore plant in the state of Maryland (northeast), although manufacturing authorization is still overdue, according to the daily.
Johnson’s vaccine is administered in a single dose, so 15 million doses are equivalent to 15 million vaccinated people.
According to the company, 20 million vaccines have already been distributed in March in the United States, according to the objectives set.
The President of the United States, Joe Biden, had announced in early March that he would seek to duplicate the country’s orders to the company, buying another 100 million vaccines, in addition to the 100 million already contracted.
Get the latest news delivered to your inbox
Follow us on social media networks